loading
loading
TTK Healthcare Q2 Results: Stock tanks 17% on weak operating performance; exceptional gain aids PAT - Edited byHormaz Fatakia - Published OnOct 30, 2026 | 16:47 IST - Last Updated OnOct 30, 2026 | 16:48 IST TTK Healthcare shares tumbled sharply as core operational profitability contracted despite a multi-fold surge in net profit driven by a massive brand divestment to Wipro Enterprises. While protective devices staged a strong turnaround, consumer product losses weighed on performance. Find out how management plans to offset core earnings pressures going forward. Shares of TTK Healthcare ended about 17% lower on Friday, October 30, marking their steepest single-day fall ever, after the company reported a 29.7% year-on-year (YoY) decline in earnings before interest, tax, depreciation and amortisation (EBITDA) to ₹3.7 crore for the September quarter from ₹5.3 crore in the corresponding quarter last year. The EBITDA margin contracted to 1.6% from 2.6% a year ago. However, revenue from operations increased 14.6% YoY to ₹233.4 crore from ₹203.6 crore in the year-ago quarter. TTK Healthcare's net profit surged to ₹223 crore from ₹20.4 crore in the year-ago quarter, largely on the back of an exceptional gain of ₹248.2 crore recognised following the sale of its EVA and GoodHome brands and related assets to Wipro Enterprises. The company said it completed the sale of its EVA and GoodHome brands and related assets to Wipro Enterprises on September 4, 2026, following a definitive agreement signed on July 23. TTK Healthcare received consideration of ₹256 crore, plus applicable goods and services tax (GST), and recognised a net gain of ₹248.2 crore after accounting for transaction-related and other directly attributable costs. The company also transferred inventories worth ₹16.5 crore to the buyer at cost as part of the asset purchase agreement. The sale of these inventories has been recognised as revenue during the quarter. Excluding exceptional items, profit before tax stood at ₹19.7 crore, compared with ₹21.3 crore in the year-ago period, indicating a decline of around 7.3%. Segment performance The company's protective devices segment reported revenue of ₹65.6 crore during the quarter, compared with ₹48.8 crore a year earlier. The segment reported a profit of ₹7.6 crore, against a loss of ₹10.2 crore in the corresponding quarter last year. Revenue from medical devices increased to ₹29.3 crore from ₹25.6 crore, while segment profit declined to ₹5 crore from ₹6.1 crore. The animal welfare segment reported revenue of ₹41.2 crore, compared with ₹35.5 crore a year ago. Its segment profit stood at ₹2.9 crore, against ₹3.2 crore in the year-ago quarter. Consumer products revenue declined to ₹54.6 crore from ₹56.3 crore. The segment reported a loss of ₹40.7 lakh, compared with a profit of ₹9.6 crore in the corresponding quarter last year. The foods segment reported revenue of ₹42.6 crore, up from ₹37.3 crore, while segment profit increased to ₹4.5 crore from ₹3.8 crore. Shares of TTK Healthcare ended 17% lower following the results announcement on Friday. Today's losses have pushed the stock into negative territory for the year, with the shares declining 13% so far in 2026 and about 14% over the last 12 months.
document fetched 2026-10-31 02:56 · canonical https://cnbctv18.com/market/ttk-healthcare-share-price-plunge-q2-results-ebitda-falls-revenue-exceptional-gain-boosts-profit-20023333.htm